SAYDAM, G. Et Al. 2016. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. EXPERT OPINION ON PHARMACOTHERAPY , vol.17, no.14 , 1851-1858.

SAYDAM, G., HAZNEDAROĞLU, İ. C., KAYNAR, L., Yavuz, A., Ali, R., GÜVENÇ, B., ... AKAY, O. M.(2016). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. EXPERT OPINION ON PHARMACOTHERAPY , vol.17, no.14, 1851-1858.

SAYDAM, GÜRAY Et Al. "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase," EXPERT OPINION ON PHARMACOTHERAPY , vol.17, no.14, 1851-1858, 2016

SAYDAM, GÜRAY Et Al. "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase." EXPERT OPINION ON PHARMACOTHERAPY , vol.17, no.14, pp.1851-1858, 2016

SAYDAM, G. Et Al. (2016) . "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase." EXPERT OPINION ON PHARMACOTHERAPY , vol.17, no.14, pp.1851-1858.

@article{article, author={GÜRAY SAYDAM Et Al. }, title={Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase}, journal={EXPERT OPINION ON PHARMACOTHERAPY}, year=2016, pages={1851-1858} }